# Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults

> **NCT00698893** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 16 (actual)

## Conditions studied

- Herpes Simplex

## Interventions

- **BIOLOGICAL:** Herpes simplex candidate (gD) vaccine GSK208141

## Key facts

- **NCT ID:** NCT00698893
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1992-05-01
- **Primary completion:** 1992-07-01
- **Final completion:** 1992-07-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2017-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00698893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00698893, "Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive Adults". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00698893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*